She set up the state-of-the-art next generation sequencing platform and established an array of sequencing based functional genomics technologies and associated analyses to systematically characterize transcription regulatory mechanisms in eukaryotic genomes. Dr. Wei moved to JGI after an eight-year stint at Genome Institute of Singapore (GIS) and was responsible for establishing a sequencing technology platform and genome biology program. She started her scientific career as a research scientist at Large Scale Biology Corporation (LSBC) where she built a research team specialized in cDNA-based analysis for gene discovery and as the key platform for the functional genomic program after a 3-year postdoctoral training at Massachusetts Institute of Technology (MIT) focused on Drosophila development and apoptosis.

Dr. Wei group’s research activity involves the development of innovative sequencing-based genomic technologies to explore functional genomic elements for transcriptional and epigenetic regulation. She applies these approaches to interrogate genomic, characterize transcriptomes and chromatin structures pertinent to the pluripotency nature of stem cells, particularly uncovering the system biology networks in lineage specification and organism development and adaptation.